Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
US Army
US Department of Justice

Generated: February 20, 2018

DrugPatentWatch Database Preview

Claims for Patent: 7,119,106

« Back to Dashboard

Summary for Patent: 7,119,106
Title:Pharmaceutical compositions of 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline
Abstract:Substituted 2-(2,6-dioxopiperidin-3-yl)phthalimides and 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines reduce the levels of TNF.alpha. in a mammal. Typical embodiments are 1-oxo-2-(2,6-dioxo-3-methylpiperidin-3-yl)-4,5,6,7-tetrafuoroisoindoline and 1,3-dioxo-2-(2,6-dioxo-3 -methylpiperidin-3-yl)-4-aminoisoindoline.
Inventor(s): Muller; George W. (Bridgewater, NJ), Stirling; David I. (Branchburg, NJ), Chen; Roger Shen-Chu (Edison, NJ)
Assignee: Celgene Corporation (Summit, NJ)
Application Number:10/337,602
Patent Claims: 1. A pharmaceutical composition comprising an effective amount of a compound of the formula: ##STR00007## or an acid addition salt thereof, and a pharmaceutically acceptable carrier, diluent or excipient.

2. The pharmaceutical composition of claim 1, which is suitable for oral administration.

3. The pharmaceutical composition of claim 2, which is in the form of a tablet or a capsule.

4. The pharmaceutical composition of claim 2, wherein the compound is present in an amount of 1 to 100 mg.

5. The pharmaceutical composition of claim 1, which is suitable for parenteral administration.

6. The pharmaceutical composition of clalm 5, which comprises a sterile injectable solution.

7. The pharmaceutical composition of claim 5, wherein the compound is present in a concentration of 20 to 100 mg/mL.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
US Department of Justice
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.